Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer

BACKGROUND: Adjuvant endocrine therapy beyond 5 years reduces recurrence in patients with estrogen receptor–positive breast cancer. We have previously shown that immunohistochemical markers (IHC4) and two gene expression profile tests (recurrence score [RS] and PAM50 risk of recurrence [ROR]) are as...

Descripción completa

Detalles Bibliográficos
Autores principales: Sestak, Ivana, Dowsett, Mitch, Zabaglo, Lila, Lopez-Knowles, Elena, Ferree, Sean, Cowens, J. Wayne, Cuzick, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787911/
https://www.ncbi.nlm.nih.gov/pubmed/24029245
http://dx.doi.org/10.1093/jnci/djt244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787911/
https://www.ncbi.nlm.nih.gov/pubmed/24029245
http://dx.doi.org/10.1093/jnci/djt244

Ejemplares similares